Literature DB >> 17319851

Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population.

Maria J Worsham1, Judith Abrams, Usha Raju, Alissa Kapke, Mei Lu, Jingfang Cheng, Donna Mott, Sandra R Wolman.   

Abstract

Women with benign breast diseases (BBD), particularly those with lesions classified as proliferative, have previously been reported to be at increased risk for subsequent development of breast cancer (BC). A cohort of 4970 women with biopsy-proven BBD, identified after histopathology review of BBD biopsies, was studied for determination of subsequent development of BC. We report on 4537 eligible women, 28% of whom are African-American, whose BBD mass was evaluable for pathologic assessment of breast tissue. Ascertainment of subsequent progression to BC from BBD was accomplished through examination of the tumor registries of the Henry Ford Health system, the Detroit SEER registry, and the State of Michigan cancer registry. Incidence rates (IR) are reported per 100,000 person years at risk (100 k pyr). Poisson regression models were used to evaluate the association of demographic and lesion characteristics with BC incidence, using person years at the time of BBD diagnosis as the offset variable. The estimated overall BC IR for this cohort is 452 (95% confidence interval [CI] = 394-519) per 100 k pyr. Incidence for women age 50 and older is 80% greater than for younger women (p = 0.007, IRR = 1.8, 95% CI = 1.36-2.36). Neither marital status (p = 0.91, IRR = 0.97, 95% CI = 0.73-1.29) nor race (p = 0.67, IRR = 0.9, 95% CI = 0.54-1.48) is associated with differences in BC IR. Compared with women having nonproliferative lesions, the risk for BC is greater for women with atypical ductal hyperplasia of (IRR = 5.0; 95%CI = 2.26-11.0; p < 0.001) and other proliferative lesions (IR = 1.7, 95% CI = 1.02-2.95; p = 0.04). BC risk for woman with atypical lesions is significantly higher than for women with proliferative lesions without atypia (IRR = 2.58, 95% CI = 1.35-4.90; p = 0.0039). Neither race nor marital status was a factor for BC incidence from BBD in this cohort. Age retained its importance as a predictor of risk. BBD lesion histopathology in the outcome categories of either proliferative without atypia or proliferative with atypia are significant risk factors for BC, even when adjusted for the influence of demographic characteristics. The risks associated with BBD histological classifications were not different across races.

Entities:  

Mesh:

Year:  2007        PMID: 17319851      PMCID: PMC1828132          DOI: 10.1111/j.1524-4741.2007.00388.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  26 in total

1.  An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions.

Authors:  S R Wellings; H M Jensen; R G Marcum
Journal:  J Natl Cancer Inst       Date:  1975-08       Impact factor: 13.506

2.  Chronic mastopathy and breast cancer. A follow-up study.

Authors:  D Kodlin; E E Winger; N L Morgenstern; U Chen
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

Review 3.  Etiology of human breast cancer: a review.

Authors:  B MacMahon; P Cole; J Brown
Journal:  J Natl Cancer Inst       Date:  1973-01       Impact factor: 13.506

4.  Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer.

Authors:  M M Black; T H Barclay; S J Cutler; B F Hankey; A J Asire
Journal:  Cancer       Date:  1972-02       Impact factor: 6.860

5.  Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk.

Authors:  C Byrne; J L Connolly; G A Colditz; S J Schnitt
Journal:  Cancer       Date:  2000-11-15       Impact factor: 6.860

6.  Benign breast disease and the risk of breast cancer.

Authors:  Lynn C Hartmann; Thomas A Sellers; Marlene H Frost; Wilma L Lingle; Amy C Degnim; Karthik Ghosh; Robert A Vierkant; Shaun D Maloney; V Shane Pankratz; David W Hillman; Vera J Suman; Jo Johnson; Cassann Blake; Thea Tlsty; Celine M Vachon; L Joseph Melton; Daniel W Visscher
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

7.  Chronic mastitis and carcinoma of the breast.

Authors:  R R Monson; S Yen; B MacMahon
Journal:  Lancet       Date:  1976-07-31       Impact factor: 79.321

8.  Lower-category benign breast disease and the risk of invasive breast cancer.

Authors:  Jiping Wang; Joseph P Costantino; Elizabeth Tan-Chiu; D Lawrence Wickerham; Soonmyung Paik; Norman Wolmark
Journal:  J Natl Cancer Inst       Date:  2004-04-21       Impact factor: 13.506

9.  Trends in breast cancer by race and ethnicity.

Authors:  Asma Ghafoor; Ahmedin Jemal; Elizabeth Ward; Vilma Cokkinides; Robert Smith; Michael Thun
Journal:  CA Cancer J Clin       Date:  2003 Nov-Dec       Impact factor: 508.702

10.  Benign breast lesions and subsequent breast carcinoma in Rochester, Minnesota.

Authors:  P K Donnelly; K W Baker; J A Carney; W M O'Fallon
Journal:  Mayo Clin Proc       Date:  1975-11       Impact factor: 7.616

View more
  22 in total

1.  Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women.

Authors:  Amy C Degnim; William D Dupont; Derek C Radisky; Robert A Vierkant; Ryan D Frank; Marlene H Frost; Stacey J Winham; Melinda E Sanders; Jeffrey R Smith; David L Page; Tanya L Hoskin; Celine M Vachon; Karthik Ghosh; Tina J Hieken; Lori A Denison; Jodi M Carter; Lynn C Hartmann; Daniel W Visscher
Journal:  Cancer       Date:  2016-06-28       Impact factor: 6.860

2.  Atypical hyperplasia of the breast--risk assessment and management options.

Authors:  Lynn C Hartmann; Amy C Degnim; Richard J Santen; William D Dupont; Karthik Ghosh
Journal:  N Engl J Med       Date:  2015-01-01       Impact factor: 91.245

3.  Benign breast disease and subsequent breast cancer: English record linkage studies.

Authors:  M J Goldacre; J D Abisgold; D G R Yeates; M P Vessey
Journal:  J Public Health (Oxf)       Date:  2010-02-12       Impact factor: 2.341

4.  Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort.

Authors:  Nur Zeinomar; Kelly-Anne Phillips; Mary B Daly; Roger L Milne; Gillian S Dite; Robert J MacInnis; Yuyan Liao; Rebecca D Kehm; Julia A Knight; Melissa C Southey; Wendy K Chung; Graham G Giles; Sue-Anne McLachlan; Michael L Friedlander; Prue C Weideman; Gord Glendon; Stephanie Nesci; Irene L Andrulis; Saundra S Buys; Esther M John; John L Hopper; Mary Beth Terry
Journal:  Int J Cancer       Date:  2019-02-20       Impact factor: 7.396

5.  Benign breast disease heterogeneity: association with histopathology, age, and ethnicity.

Authors:  Jingfang Cheng; Shijing Qiu; Usha Raju; Sandra R Wolman; Maria J Worsham
Journal:  Breast Cancer Res Treat       Date:  2007-10-05       Impact factor: 4.872

6.  DNA repair gene variants associated with benign breast disease in high cancer risk women.

Authors:  Timothy J Jorgensen; Kathy J Helzlsouer; Sandra C Clipp; Judy Hoffman Bolton; Rosa M Crum; Kala Visvanathan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

7.  Risk factors for breast cancer from benign breast disease in a diverse population.

Authors:  Maria J Worsham; Usha Raju; Mei Lu; Alissa Kapke; Alyssa Botttrell; Jingfang Cheng; Varsha Shah; Adnan Savera; Sandra R Wolman
Journal:  Breast Cancer Res Treat       Date:  2008-10-04       Impact factor: 4.872

Review 8.  Short-term imaging follow-up of patients with concordant benign breast core needle biopsies: is it really worth it?

Authors:  Michelle C Adams; Shannon Falcon; Blaise P Mooney; Christine Laronga; Alec Chau; Jennifer S Drukteinis
Journal:  Diagn Interv Radiol       Date:  2014-11       Impact factor: 2.630

9.  Clinical characteristics of breast cancers in African-American women with benign breast disease: a comparison to the surveillance, epidemiology, and end results program.

Authors:  Susanna D Mitro; Rouba Ali-Fehmi; Sudeshna Bandyopadhyay; Baraa Alosh; Bassam Albashiti; Derek C Radisky; Marlene H Frost; Amy C Degnim; Julie J Ruterbusch; Michele L Cote
Journal:  Breast J       Date:  2014-09-08       Impact factor: 2.431

10.  Benign breast disease and the risk of subsequent breast cancer in African American women.

Authors:  Michele L Cote; Julie J Ruterbusch; Barra Alosh; Sudeshna Bandyopadhyay; Elizabeth Kim; Bassam Albashiti; Bashar Sharaf Aldeen; Derek C Radisky; Marlene H Frost; Daniel W Visscher; Lynn C Hartmann; Warzecha Hind Nassar; Rouba Ali-Femhi
Journal:  Cancer Prev Res (Phila)       Date:  2012-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.